The global medical polymer splint market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market can be attributed to the increasing number of orthopedic surgeries and rising demand for minimally invasive procedures, which are driving the demand for medical polymer splints in hospitals and clinics.
The global medical polymer splint market is segmented on the basis of type into glass fiber, polyurethane, resin; on the basis of application into hospital and clinical; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The North American region accounted for a major share in 2017 owing to high adoption rates among hospitals in this region. However, APAC is expected to witness significant growth during the forecast period due to increasing healthcare expenditure coupled with growing awareness about minimally invasive procedures among patients in this region.
- The increasing number of people suffering from chronic diseases such as arthritis and diabetes is expected to drive the demand for medical polymer splints.
- The growing awareness about the benefits of using medical polymer splints is also expected to fuel the growth of this market.
- The increasing number of orthopedic surgeries, which are often followed by a period of immobilization, will also boost the demand for medical polymer splints in this market over the forecast period.
- Increasing geriatric population base will lead to an increase in demand for medical polymer splints in this market over the forecast period.
- Increasing disposable income levels and rising healthcare expenditure are also expected to fuel growth in this market.
Industry Growth Insights published a new data on “Medical Polymer Splint Market”. The research report is titled “Medical Polymer Splint Market research by Types (Glass fiber, Polyurethane, Resin, Other), By Applications (Hospital, Clinical, Other), By Players/Companies Glaxsan Pharma, Tuoren, Performance Health, Topcare Biotech, AdvaCare Pharma, Jiangsu Maibang Biotechnology, Shandong Haidi Ke Biotechnology, Shaanxi Yuanguang High Technology, Jinan Tasite Biotechnology, Anhui Ankang Health Materials, Wuxi S&Y”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Medical Polymer Splint Market Research Report
By Type
Glass fiber, Polyurethane, Resin, Other
By Application
Hospital, Clinical, Other
By Companies
Glaxsan Pharma, Tuoren, Performance Health, Topcare Biotech, AdvaCare Pharma, Jiangsu Maibang Biotechnology, Shandong Haidi Ke Biotechnology, Shaanxi Yuanguang High Technology, Jinan Tasite Biotechnology, Anhui Ankang Health Materials, Wuxi S&Y
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Medical Polymer Splint Market Report Segments:
The global Medical Polymer Splint market is segmented on the basis of:
Types
Glass fiber, Polyurethane, Resin, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinical, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Glaxsan Pharma
- Tuoren
- Performance Health
- Topcare Biotech
- AdvaCare Pharma
- Jiangsu Maibang Biotechnology
- Shandong Haidi Ke Biotechnology
- Shaanxi Yuanguang High Technology
- Jinan Tasite Biotechnology
- Anhui Ankang Health Materials
- Wuxi S&Y
Highlights of The Medical Polymer Splint Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Glass fiber
- Polyurethane
- Resin
- Other
- By Application:
- Hospital
- Clinical
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Medical Polymer Splint Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A medical polymer splint is a type of splint that is made from medical-grade polymers. These polymers are often used to help stabilize broken bones or other injuries, and they can be molded to fit the individual's body perfectly. Medical polymer splints are often less bulky than traditional metal or plastic splints, and they can be worn for long periods of time without causing discomfort.
Some of the key players operating in the medical polymer splint market are Glaxsan Pharma, Tuoren, Performance Health, Topcare Biotech, AdvaCare Pharma, Jiangsu Maibang Biotechnology, Shandong Haidi Ke Biotechnology, Shaanxi Yuanguang High Technology, Jinan Tasite Biotechnology, Anhui Ankang Health Materials, Wuxi S&Y.
The medical polymer splint market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Polymer Splint Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Medical Polymer Splint Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Medical Polymer Splint Market - Supply Chain
4.5. Global Medical Polymer Splint Market Forecast
4.5.1. Medical Polymer Splint Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Medical Polymer Splint Market Size (000 Units) and Y-o-Y Growth
4.5.3. Medical Polymer Splint Market Absolute $ Opportunity
5. Global Medical Polymer Splint Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Medical Polymer Splint Market Size and Volume Forecast by Type
5.3.1. Glass fiber
5.3.2. Polyurethane
5.3.3. Resin
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Medical Polymer Splint Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Medical Polymer Splint Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinical
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Medical Polymer Splint Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Medical Polymer Splint Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Medical Polymer Splint Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Medical Polymer Splint Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Medical Polymer Splint Demand Share Forecast, 2019-2026
9. North America Medical Polymer Splint Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Medical Polymer Splint Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Medical Polymer Splint Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinical
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Medical Polymer Splint Market Size and Volume Forecast by Type
9.7.1. Glass fiber
9.7.2. Polyurethane
9.7.3. Resin
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Medical Polymer Splint Demand Share Forecast, 2019-2026
10. Latin America Medical Polymer Splint Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Medical Polymer Splint Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Medical Polymer Splint Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinical
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Medical Polymer Splint Market Size and Volume Forecast by Type
10.7.1. Glass fiber
10.7.2. Polyurethane
10.7.3. Resin
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Medical Polymer Splint Demand Share Forecast, 2019-2026
11. Europe Medical Polymer Splint Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Medical Polymer Splint Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Medical Polymer Splint Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinical
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Medical Polymer Splint Market Size and Volume Forecast by Type
11.7.1. Glass fiber
11.7.2. Polyurethane
11.7.3. Resin
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Medical Polymer Splint Demand Share, 2019-2026
12. Asia Pacific Medical Polymer Splint Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Medical Polymer Splint Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Medical Polymer Splint Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinical
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Medical Polymer Splint Market Size and Volume Forecast by Type
12.7.1. Glass fiber
12.7.2. Polyurethane
12.7.3. Resin
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Medical Polymer Splint Demand Share, 2019-2026
13. Middle East & Africa Medical Polymer Splint Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Medical Polymer Splint Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Medical Polymer Splint Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinical
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Medical Polymer Splint Market Size and Volume Forecast by Type
13.7.1. Glass fiber
13.7.2. Polyurethane
13.7.3. Resin
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Medical Polymer Splint Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Medical Polymer Splint Market: Market Share Analysis
14.2. Medical Polymer Splint Distributors and Customers
14.3. Medical Polymer Splint Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Glaxsan Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Tuoren
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Performance Health
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Topcare Biotech
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AdvaCare Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Jiangsu Maibang Biotechnology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shandong Haidi Ke Biotechnology
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shaanxi Yuanguang High Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Jinan Tasite Biotechnology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Anhui Ankang Health Materials
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Wuxi S&Y
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
